This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0-ballot: STU4 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 3.0.0. For a full list of available versions, see the Directory of published versions
Generated Narrative: MedicationRequest
Resource MedicationRequest "cancer-related-medication-request-cisplatin"
Procedure Intent Extension: Curative - procedure intent (SNOMED CT#373808002)
status: completed
intent: order
medication: CISplatin 50 MG per 50 ML Injectable Solution (RxNorm#309311)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
authoredOn: 2019-04-01
requester: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
reasonCode: Non-small cell lung cancer (disorder) (SNOMED CT#254637007)
note: Day 1 of NSCLC regimen: Cisplatin 75 mg/m2 day 1; docetaxel 75 mg/m2 day 1 every 21 days for 4 cycles.
dosageInstruction
text: calculate absolute dose on day of administration.
timing: Events: 2019-06-15, Count 1 times, Once
route: Intravenous use (SNOMED CT#47625008)
doseAndRate